Key result
EP4-knockout in mice leads to a paradoxical patent ductus arteriosus phenotype due to impaired contractile potential, altered signaling, and failure to remodel.
Why the study?
What is the role of the PGE2-EP4 receptor in the developmental programming and closure of the mouse ductus arteriosus?
What is the role of the PGE2-EP4 receptor in the developmental programming and closure of the mouse ductus arteriosus?
The EP4 receptor is critical for ductus arteriosus maturation and closure, offering a mechanistic explanation for unexplained PDA in infants exposed to maternal NSAIDs.
NSAIDs in preterm labor may raise PDA risk; leaves open EP4 modulation as a therapeutic target pending human validation.
EP4 is the primary EP receptor in the ductus arteriosus (DA) and is critical during late gestation for its development and eventual closure. The “paradoxical” patent DA (PDA) phenotype of EP4-knockout mice arises from a combination of impaired contractile potential, altered signaling properties, and a failure to remodel associated with an underdeveloped immature vessel. These findings provide new mechanistic insights into women who receive NSAIDs to treat preterm labor, whose infants have unexplained PDA.
No takes yet. Share an insight, caveat, or question.
Yarboro et al. (2023) studied Patent ductus arteriosus. EP4-knockout was evaluated on Ductus arteriosus development and closure. EP4-knockout in mice leads to a paradoxical patent ductus arteriosus phenotype due to impaired contractile potential, altered signaling, and failure to remodel.